GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Cyclically Adjusted Revenue per Share

Covalon Technologies (Covalon Technologies) Cyclically Adjusted Revenue per Share : $0.78 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Covalon Technologies's adjusted revenue per share for the three months ended in Dec. 2023 was $0.141. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.78 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Covalon Technologies's average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Covalon Technologies was 20.30% per year. The lowest was 5.40% per year. And the median was 10.80% per year.

As of today (2024-05-22), Covalon Technologies's current stock price is $0.7962. Covalon Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $0.78. Covalon Technologies's Cyclically Adjusted PS Ratio of today is 1.02.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Covalon Technologies was 12.75. The lowest was 0.86. And the median was 2.36.


Covalon Technologies Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Covalon Technologies's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Cyclically Adjusted Revenue per Share Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.69 0.81 0.77 0.75

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.71 0.81 0.75 0.78

Competitive Comparison of Covalon Technologies's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Covalon Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Cyclically Adjusted PS Ratio falls into.



Covalon Technologies Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Covalon Technologies's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.141/125.0724*125.0724
=0.141

Current CPI (Dec. 2023) = 125.0724.

Covalon Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.099 98.604 0.126
201406 0.149 99.473 0.187
201409 0.117 99.394 0.147
201412 0.101 98.367 0.128
201503 0.196 99.789 0.246
201506 0.172 100.500 0.214
201509 0.170 100.421 0.212
201512 0.191 99.947 0.239
201603 0.057 101.054 0.071
201606 0.140 102.002 0.172
201609 0.035 101.765 0.043
201612 0.356 101.449 0.439
201703 0.189 102.634 0.230
201706 0.164 103.029 0.199
201709 0.498 103.345 0.603
201712 0.234 103.345 0.283
201803 0.185 105.004 0.220
201806 0.247 105.557 0.293
201809 0.183 105.636 0.217
201812 0.243 105.399 0.288
201903 0.449 106.979 0.525
201906 0.232 107.690 0.269
201909 0.214 107.611 0.249
201912 0.234 107.769 0.272
202003 0.146 107.927 0.169
202006 0.191 108.401 0.220
202009 -0.187 108.164 -0.216
202012 0.079 108.559 0.091
202103 0.132 110.298 0.150
202106 0.191 111.720 0.214
202109 0.202 112.905 0.224
202112 0.149 113.774 0.164
202203 0.100 117.646 0.106
202206 0.142 120.806 0.147
202209 0.159 120.648 0.165
202212 0.181 120.964 0.187
202303 0.212 122.702 0.216
202306 0.189 124.203 0.190
202309 0.212 125.230 0.212
202312 0.141 125.072 0.141

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Covalon Technologies  (OTCPK:CVALF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Covalon Technologies's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.7962/0.78
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Covalon Technologies was 12.75. The lowest was 0.86. And the median was 2.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Covalon Technologies Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (Covalon Technologies) Business Description

Industry
Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.